Synthesis and evaluation of 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives: mixed partial agonists at mu opioid and nociception/orphanin FQ peptide receptors

Key Points

• This research aims to synthesize and evaluate new compounds that can manage severe pain with fewer side effects than traditional opioids.
• Synthesize 14β-acyl substituted 17cyclopropylmethyl-7,8-dihydromorphinone derivatives.
• Evaluate their activity as mixed partial agonists at mu opioid and nociception receptors.
• Analyze their potential as analgesics in comparison to standard opioids.
• Identified new derivatives with partial agonist properties at mu opioid receptors.
• Showed reduced adverse effects compared to traditional opioids.
• Suggested potential as effective treatments for chronic pain management.

Abstract